Optivite® PMT is the first multivitamin - multimineral supplement formulated for use by women with Premenstrual tension syndromes (PMTS). Available to PMTS sufferers over the past 20 years, Optivite® underwent several clinical studies published in peer-reviewed medical journals: 3 open trials (1-3) and 2 double blind placebo-controlled studies (4,5).
     A 50% reduction of PMTS complaints has been observed in those studies following 1 to 3 months on this supplement.
     When 313 PMTS sufferers were followed for up to 5 years on this program, an interesting observation was that the number of tablets of Optivite required to maintain the improvement in PMTS complaints decreased over time: 5.2 + 0.36 tablets between 2 and 6 months: 4.8 + 0.6 tablets between 7 and 12 months: 4.3 + 0.48 tablets between 13 and 24 months and 3.2 + 0.34 tablets over 24 months (1).
     With over 100,000 women on this program during the first 5 years of availability of Optivite®, not a single documented case of Vitamin A toxicity and peripheral neuropathy due to Vitamin B-6 has been reported (1).
     Optivite® is recommended as part of a total dietary program to obtain best results (6,7).

1] Abraham, G.E., Rumley, R.E., The Role of Nutrition in Managing the Premenstrual Tension Syndromes, J. Rep. Med., 32:405, 1987.

2] Goei, G.S., Abraham, G.E., Effect of a Nutritional Supplement, Optivite®, on Symptoms of Premenstrual Tension, J. Rep. Med., 28:527, 1983.
3] Fuchs, N., Hakim, M., Abraham, G.E., The Effect of a Nutritional Supplement, Optivite® for Women, on Premenstrual Tension Syndromes: Effect on blood chemistry and serum steroid levels during the medluteal phase, J. Appl. Nut., 37:1, 1985.
4] Chakmakjian, Z.H., Higgins, C.E., Abraham, G.E., The Effect of a Nutritional Supplement, Optivite® for Women, on Premenstrual Tension Syndromes: Effect of symptomatology, using a double blind crossover design, J. Appl. Nut., 37:12, 1985.
5] London, R.S., Bradley, L., Chiamori, N.Y., Effect of a Nutritional Supplement on Premenstrual Symptomatology in Women with Premenstrual Syndrome: A Double-Blind Longitudinal Study, J. Am. Coll. Nut., 10:494-499, 1991.
6] Abraham, G.E., Nutrition and the Premenstrual Tension Syndromes, J. Appl. Nut., 36:103, 1984.
7] Abraham, G.E., Nutritional Factors in the Etiology of the Premenstrual Tension Syndromes, J. Rep. Med., 28:446, 1983.

Supplement Facts


2-6 Tablets/day as part of the dietary program described in the brochure inside bottle, or as directed by a physician.


  1. Do not use if outer seal is broken.
  2. if pregnant or lactating, consult physician before use.
  3. Do not exceed 6 tablets a day.
  4. If taking any prescription drug, consult physician before use.
  5. Do not use for pernicious anemia, or if you have hemochromatosis or hemosiderosis.
  6. Read brochure inside bottle before use.

Accidental over dose of iron-containing products is a leading causes of fatal poisoning in children under 6. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Store in a cool, dry place.

Manufactured for
Optimox Corporation
Torrance, CA 90510-3378

[ Front Page ] [ Order Now Online ] [ Mail-in Order Form ]